
Heartflow received nationwide UnitedHealthcare coverage for its AI CT plaque analysis software and announced plans for a $200M IPO at a $1.3B valuation.
Key Details
- 1UnitedHealthcare will provide nationwide coverage for Heartflow's CT-based plaque analysis software, effective October 1.
- 2Coverage applies to all UnitedHealthcare plans, including commercial, Medicare Advantage, and dual-eligible offerings.
- 3Heartflow aims to raise up to $212.5 million by offering 12.5 million shares at $15–$17 per share in its IPO.
- 4Company generated about $43 million in Q2 2025, up 40% year-over-year.
- 5Heartflow's platform has assessed over 400,000 patients for coronary artery disease as of March 31, 2025.
- 6The US market opportunity for Heartflow's products is estimated at $5 billion.
Why It Matters
Nationwide insurer coverage and a strong IPO position solidify Heartflow's AI solution as a standard in coronary CT interpretation. This represents a significant step in the adoption and reimbursement of radiology AI, paving the way for broader clinical and commercial implementation.

Source
Radiology Business
Related News

•Health Imaging
BMI Significantly Impacts AI Accuracy in CT Lung Nodule Detection
New research demonstrates that high BMI negatively impacts both human and AI performance in chest low-dose CT interpretation, highlighting dataset diversity concerns.

•Radiology Business
Cigna Expands Nationwide Coverage for CT Imaging AI Tools
Cigna will reimburse for CT-based plaque analysis AI software for millions of members nationwide.

•AI in Healthcare
Joint Commission Issues AI Guidance; Radiology AI Advancements Highlighted
Joint Commission releases AI safety guidance while major advances surface in predictive and radiology AI models.